Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03338790
Brief Title: An Investigational Immunotherapy Study of Nivolumab in Combination With Rucaparib, Docetaxel, or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (CheckMate 9KD)

First Submitted : November 8, 2017
First Submitted that Met QC Criteria : November 8, 2017
First Posted : November 9, 2017

Last Update Submitted that Met QC Criteria : September 9, 2020
Last Update Posted : September 10, 2020